Search

Your search keyword '"Esche, H."' showing total 141 results

Search Constraints

Start Over You searched for: Author "Esche, H." Remove constraint Author: "Esche, H."
141 results on '"Esche, H."'

Search Results

2. Regulation of Viral and Cellular Gene Expression by E1A Proteins Encoded by the Oncogenic Adenovirus Type 12

6. Junges Forum II

23. Adenoviridae: Second Report.

24. Gene expression of bacteriophage SPP1

26. cAMP-independent activation of the adenovirus type 12 E2 promoter correlates with the recruitment of CREB-1/ATF-1, E1A(12S), and CBP to the E2-CRE.

27. The adenovirus type 12 ‐ mouse cell system: permissivity and analysis of integration patterns of viral DNA in tumor cells.

28. The translational map of the Autographa californica nuclear polyhedrosis virus (AcNPV) genome.

29. In vitro translation of adenovirus type 12-specific mRNA isolated from infected and transformed cells

30. Viral gene products in adenovirus type-2 transformed hamster cells

31. G protein regulation of the Na+/H+ antiporter in Xenopus laevis oocytes. Involvement of protein kinases A and C.

32. Repression of the c-Jun trans-activation function by the adenovirus type 12 E1A 52R protein correlates with the inhibition of phosphorylation of the c-Jun activation domain.

34. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents

43. Funktion des Adenovirus Serotyp 12 E1A-Gens bei der malignen Transformation primärer Mauszellen

44. Sprouty is a cytoplasmic target of adenoviral E1A oncoproteins to regulate the receptor tyrosine kinase signalling pathway.

45. Cellular uptake and toxicity of Au55 clusters.

46. A point mutation in the first splice donor leads to reduced oncogenic properties of the adenovirus serotype 12 E1A gene.

47. Tumor-specific activation of hTERT-derived promoters by tumor suppressive E1A-mutants involves recruitment of p300/CBP/HAT and suppression of HDAC-1 and defines a combined tumor targeting and suppression system.

48. Transactivation-deficient DeltaTA-p73 acts as an oncogene.

49. Improved treatment of pancreatic cancer by IL-12 and B7.1 costimulation: antitumor efficacy and immunoregulation in a nonimmunogenic tumor model.

50. Identification of the full-length huntingtin- interacting protein p231HBP/HYPB as a DNA-binding factor.

Catalog

Books, media, physical & digital resources